Full-Time

Manufacturing Associate

Posted on 3/31/2023

Orca Bio

Orca Bio

51-200 employees

Clinical-stage cell therapy company

Biotechnology

Junior, Mid

Sacramento, CA, USA

Requirements
  • Master's or bachelor's degree in biology or related field
  • 1-2 years of experience in process sciences, discovery research or manufacturing
  • Experience with aseptic techniques
  • Breadth of knowledge of cell therapy and clinical manufacturing, cell processing technologies, cell characterization methods, validation and quality systems
  • A background in immunology, oncology or cell therapy
  • Flow cytometry experience, including sorting and analyzing cells
  • Experience working with human cells
  • GMP experience and/or eagerness to learn the manufacturing process under GMP
Responsibilities
  • Faithfully execute scientific protocols
  • Develop cell therapy for blood diseases
  • Optimize cell assays
  • Use cell separation technologies
  • Perform flow cytometry and analyze data
  • Work with new technology
  • Review and support continuous improvements of records and SOPs
  • Analyze results, maintain detailed records of experiments and outcomes
  • Participate in group research discussions
  • Prepare, maintain, trouble-shoot, and operate instruments
  • Participate in group research discussions
  • Highly detail-oriented, and pays special attention to quality and quality control
  • A multi-tasker who can handle and prioritize multiple responsibilities simultaneously
  • Curious to learn and eager to step-up immediately in a fast-paced, collaborative start-up environment
  • Able to work both independently and as part of a team, and seamlessly transition between the two
  • Strong problem-solving skills with the desire to improve upon established processes
  • Eager to onboard, train, and mentor new team members

Abata's mission is to translate the biology of regulatory T cells (Tregs) into transformational medicines for patients with progressive multiple sclerosis and other serious autoimmune and inflammatory diseases. Abata is bringing an entirely new approach to the treatment of autoimmune disease by engineering Tregs as targeted therapies that stop immune-mediated destruction, restore homeostasis – a state of harmony – and promote repair in the affected tissues.

Company Stage

Series D

Total Funding

$375M

Headquarters

Menlo Park, California

Founded

2016

Growth & Insights
Headcount

6 month growth

4%

1 year growth

24%

2 year growth

38%
INACTIVE